Literature DB >> 21711087

Recent progress in therapeutic applications of chalcones.

Anna-Maria Katsori1, Dimitra Hadjipavlou-Litina.   

Abstract

INTRODUCTION: Chalcones are a group of plant-derived polyphenolic compounds belonging to the flavonoids family that possess a wide variety of cytoprotective and modulatory functions, which may have therapeutic potential for multiple diseases. Their physicochemical properties seem to define the extent of their biological activity. AREAS COVERED: A comprehensive synopsis of recent patent literature (2005 - 2011) describing chalcones and their derivatives on selected activities (e.g., anti-inflammatory, antimitotic, cytotoxic, antioxidant, anti-infection) is provided in this paper. Synthesis, combinatorial techniques, biological evaluation in vitro/in vivo, and new biological assays are discussed. In addition to selected biological data, a wide range of pharmaceutical applications and pharmaceutical compositions are also summarized. EXPERT OPINION: Several natural and synthetic chalcones and their derivatives appear as promising anti-inflammatory and anticancer activities. Their clinical evaluation will be critical to assess their therapeutic utility. Those for which the mechanism of action is well defined can serve as lead compounds for the design of new, more promising molecules.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21711087     DOI: 10.1517/13543776.2011.596529

Source DB:  PubMed          Journal:  Expert Opin Ther Pat        ISSN: 1354-3776            Impact factor:   6.674


  12 in total

1.  Novel synthetic chalcones induce apoptosis in the A549 non-small cell lung cancer cells harboring a KRAS mutation.

Authors:  Yiqiang Wang; Andreas Hedblom; Steffi K Koerner; Mailin Li; Finith E Jernigan; Barbara Wegiel; Lijun Sun
Journal:  Bioorg Med Chem Lett       Date:  2016-10-24       Impact factor: 2.823

2.  Synthesis, characterization, and computational study of a new dimethoxy-chalcone.

Authors:  Ricardo R Ternavisk; Ademir J Camargo; Francisco B C Machado; José A F F Rocco; Gilberto L B Aquino; Valter H C Silva; Hamilton B Napolitano
Journal:  J Mol Model       Date:  2014-11-25       Impact factor: 1.810

3.  Regiospecificity of human UDP-glucuronosyltransferase isoforms in chalcone and flavanone glucuronidation determined by metal complexation and tandem mass spectrometry.

Authors:  Emily D Niemeyer; Jennifer S Brodbelt
Journal:  J Nat Prod       Date:  2013-05-29       Impact factor: 4.050

4.  Pharmacokinetic Studies of Oxathio-Heterocycle Fused Chalcones.

Authors:  Krystyna Okoniewska; Marek T Konieczny; Krzysztof Lemke; Tomasz Grabowski
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-02       Impact factor: 2.441

5.  The chalcone derivative (E)-1-(4-fluoro-phen-yl)-3-(4-hy-droxy-3-meth-oxy-phen-yl)prop-2-en-1-one monohydrate.

Authors:  Florastina Payton-Stewart; Subramanya Ravi Kiran Pingali; James P Donahue
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-03-23

6.  Crystal structure of (E)-2-[(2-bromopyridin-3-yl)methyl-idene]-6-meth-oxy-3,4-di-hydro-naphthalen-1(2H)-one and 3-[(E)-(6-meth-oxy-1-oxo-1,2,3,4-tetra-hydro-naphthalen-2-ylidene)meth-yl]pyridin-2(1H)-one.

Authors:  Sarah K Zingales; Morgan E Moore; Andrew D Goetz; Clifford W Padgett
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2016-06-14

7.  Biological Effect of Licochalcone C on the Regulation of PI3K/Akt/eNOS and NF-κB/iNOS/NO Signaling Pathways in H9c2 Cells in Response to LPS Stimulation.

Authors:  Sara Franceschelli; Mirko Pesce; Alessio Ferrone; Daniela Maria Pia Gatta; Antonia Patruno; Maria Anna De Lutiis; José Luis Quiles; Alfredo Grilli; Mario Felaco; Lorenza Speranza
Journal:  Int J Mol Sci       Date:  2017-03-23       Impact factor: 5.923

8.  Isobavachalcone from Angelica keiskei Inhibits Adipogenesis and Prevents Lipid Accumulation.

Authors:  Hyejin Lee; Hua Li; Minson Kweon; Youngsook Choi; Min Jung Kim; Jae-Ha Ryu
Journal:  Int J Mol Sci       Date:  2018-06-06       Impact factor: 5.923

9.  (2E)-3-(4-Methyl-phen-yl)-1-(pyridin-3-yl)prop-2-en-1-one.

Authors:  Mauricio de Sousa Oliveiria; Wanderson Costa de Souza; Hamilton B Napolitano; Allen G Oliver
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-07-28

10.  Quantum mechanical, spectroscopic and docking studies of (2E)-1-(4-aminophenyl)-3-(4-benzyloxyphenyl)-prop-2-en-1-one Chalcone derivative by density functional theory - A prospective respiratory drug.

Authors:  T Hannah Clara; S Muthu; Johanan Christian Prasana
Journal:  Mater Today Proc       Date:  2020-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.